FSD Pharma Inc. has come a long way. 💪🏻 FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) hired an outside consultant to assess its main medicinal component, ultramicronized palmitoylethanolamide (PEA), or FSD201, more extensively in order to assess its current commercial viability.